Zusammenfassung
Bei der Portimplantation kann es zu einer vermehrten Blutungsneigung kommen, wenn bei dem Patienten Gerinnungsdefekte vorliegen. Thrombotische Ereignisse sowie Okklusionen sind wichtige Komplikationen implantierter Portsysteme. Somit sind hämostaseologische Grundkenntnisse von Bedeutung, um die genannten Komplikationen zu vermeiden bzw. auftretende Komplikationen adäquat therapieren zu können
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Agnelli G, Verso M (2006) Therapy insight: venous-catheterrelated thrombosis in cancer patients. Nature Clin Pract 3: 214–222
Couban S, Goodyear M, Burnell M et al. (2005) Randomized, placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23: 4063–4069
Dai MS, Hsieh AT, Chao TY (2004) Catastrophic heparininduced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy. Support Care Cancer 12: 537–539
Faintuch S, Salazar GM (2008) Malfunction of dialysis catheters: management of fibrin sheath and related problems. Tech Vasc Interv Radiol 11: 195–200
Goossens GA, Jérôme M, Janssens C et al. (2013) Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol 24: 1892–1899
Holcombe BJ, Forloines-Lynn S, Garmhausen LW (1992) Restoring patency of long-term central venous access devices. J Intraven Nurs 15: 36–41
Koscielny J, Ziemer S, Radtke H et al. (2004) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 195–204
Koscielny J, Ziemer S, Radtke H et al. (2007) Preoperative identification of patients with impaired (primary) haemostasis. A practical concept. Hamostaseologie 27: 177–184
Mandalà M, Curigliano G, Bucciarelli P et al. (2004) Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol 15: 590–593
Monreal M, Alastrue A, Rull M et al. (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices – prophylaxis with a low molecular weight heparin (fragmin). Thromb Haemost 75: 251–253
Pfanner G, Koscielny J, Pernerstorfer T et al. (2007) Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care. Anaesthesist 56: 604–611
Rabe C, Gramann T, Sons X et al. (2002) Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med 28: 1172–1176
Roberts HR, Hoffman M, Monroe DM (2006) A cell-based model of thrombin generation. Semin Thromb Haemost 32 (Suppl 1): 32–38
Schmaier AH (2008) The elusive physiologic role of factor XII. J Clin Invest 118: 3006–3009
Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous thrombosis. N Engl J Med 344: 1222–1231
Shang E, Geiger N, Sturm J, Post S (2003) Heparin induzierte Thrombozythopathie (HIT) Risiko bei intravenösen Portsystemen. Aktuel Ernaehr 28: 191–208
Stephens LC, Haire WD, Tarantolo S et al. (1997) Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC). Transfus Sci 18: 187–193
Sugimoto K, Hofmann LV, Razavi MK et al. (2003) The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg 2003; 37: 512–517
Sutherland DE, Weitz IC, Liebman HA (2003) Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis and treatment. Am J Hematol 72: 43–52
Teichgräber UK, Pfitzmann R, Hofmann HAF (2011) Portsysteme als integraler Bestandteil von Chemotherapien. Deutsch Ärztebl 108; 147–154
Teichgräber UK, Nagel SN, Kausche S, Enzweiler C (2012) Clinical benefit of power-injectable port systems: a prospective observational study. Eur J Radiol 81: 528–533
Verso M, Agnelli G, Bertoglio S et al. (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebocontrolled, randomized study in cancer patients. J Clin Oncol 23: 4057–4062
Vescia S, Baumgärtner AK, Jacobs VR et al. (2008) Management of venous port systems in oncology: a review of current evidence. Ann Oncol 19: 9–15
Virchow RLK (1856) Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Thrombose und Embolie. Gefäßentzündung und septische Infektion. Von Meidinger & Sohn, Frankfurt am Main, S 219–732
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sucker, C. (2016). Gerinnung, Thrombosen, Blutungen, Okklusionen in der Portchirurgie. In: Hennes, R., Hofmann, H. (eds) Ports. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43641-7_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-43641-7_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43640-0
Online ISBN: 978-3-662-43641-7
eBook Packages: Medicine (German Language)